These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 2053325)

  • 21. Storage of platelets in additive solutions: effects of phosphate.
    Gulliksson H; Larsson S; Kumlien G; Shanwell A
    Vox Sang; 2000; 78(3):176-84. PubMed ID: 10838519
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cryopreservation of buffy-coat-derived platelet concentrates in dimethyl sulfoxide and platelet additive solution.
    Johnson LN; Winter KM; Reid S; Hartkopf-Theis T; Marks DC
    Cryobiology; 2011 Apr; 62(2):100-6. PubMed ID: 21241687
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Platelet concentrates stored in synthetic medium after filtration.
    Bertolini F; Rebulla P; Marangoni F; Sirchia G
    Vox Sang; 1992; 62(2):82-6. PubMed ID: 1519372
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel system for storage of buffy-coat-derived platelet concentrates in a glucose-based platelet additive solution: parameters and metabolism during storage and comparison to plasma.
    Gyongyossy-Issa MI; Zhang JG; Culibrk B; Hunter F; Levin E; Scammell K; Weiss S; Holmes DL; Holme S
    Vox Sang; 2009 Aug; 97(2):102-9. PubMed ID: 19508670
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of the Impact-R for monitoring the platelet storage lesion.
    Albanyan AM; Murphy MF; Harrison P
    Platelets; 2009 Feb; 20(1):1-6. PubMed ID: 19172514
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro function of platelet concentrates prepared after filtration of whole blood or buffy coat pools.
    Turner CP; Sutherland J; Wadhwa M; Dilger P; Cardigan R
    Vox Sang; 2005 Apr; 88(3):164-71. PubMed ID: 15787726
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Platelets stored in a new-generation container differences between plasma and platelet additive solution II.
    de Wildt-Eggen J; Schrijver JG; Smid WM; Joie M; Bollinne V; Bins M
    Vox Sang; 1998; 75(3):218-23. PubMed ID: 9852410
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overnight or fresh buffy coat-derived platelet concentrates prepared with various platelet pooling systems.
    Dijkstra-Tiekstra MJ; Kuipers W; Setroikromo AC; de Wildt-Eggen J
    Transfusion; 2008 Apr; 48(4):723-30. PubMed ID: 18208415
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of platelet function during extended storage in additive solution, prepared in a new container that allows manual buffy-coat platelet pooling and leucoreduction in the same system.
    Plaza EM; Lozano ML; Guiu IS; Egea JM; Vicente V; De Terán LC; Rivera J
    Blood Transfus; 2012 Oct; 10(4):480-9. PubMed ID: 22682335
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of glucose and acetate on the characteristics of the platelet storage lesion in platelets suspended in additive solutions with minimal plasma.
    Saunders C; Rowe G; Wilkins K; Collins P
    Vox Sang; 2013 Jul; 105(1):1-10. PubMed ID: 23347286
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Quality of thrombocyte preparations from buffy coat or platelet-rich plasma].
    Bux J; Müller K; Misterek J; Mueller-Eckhardt C
    Beitr Infusionsther; 1990; 26():99-102. PubMed ID: 1703912
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Restoration of in vitro responses in platelets stored in plasma.
    Mondoro TH; Shafer BC; Vostal JG
    Am J Clin Pathol; 1999 May; 111(5):693-9. PubMed ID: 10230361
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quality of platelet concentrates derived by platelet rich plasma, buffy coat and Apheresis.
    Vasconcelos E; Figueiredo AC; Seghatchian J
    Transfus Apher Sci; 2003 Aug; 29(1):13-6. PubMed ID: 12877887
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of the addition of second-messenger effectors to platelet concentrates separated from whole-blood donations and stored at 4 degrees C or -80 degrees C.
    Lozano M; Escolar G; Mazzara R; Connor J; White JG; DeLecea C; Ordinas A
    Transfusion; 2000 May; 40(5):527-34. PubMed ID: 10827254
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ultrastructural changes and activation differences in platelet concentrates stored in plasma and additive solution.
    Wagner T; Vetter A; Dimovic N; Guber SE; Helmberg W; Kröll W; Lanzer G; Mayr WR; Neumüller J
    Transfusion; 2002 Jun; 42(6):719-27. PubMed ID: 12147024
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Buffy-coat-derived platelet concentrates prepared from half-strength citrate CPD and CPD whole-blood units. Comparison between three additive solutions: in vitro studies.
    Gulliksson H; Eriksson L; Högman CF; Payrat JM
    Vox Sang; 1995; 68(3):152-9. PubMed ID: 7625071
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Platelet concentrates in an additive solution prepared from pooled buffy coats. 1. In vitro studies.
    Eriksson L; Högman CF
    Vox Sang; 1990; 59(3):140-5. PubMed ID: 2264316
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of platelet function using the in vitro bleeding time and corrected count increment of transfused platelets. Comparison between platelet concentrates derived from pooled buffy coates and apheresis.
    Eriksson L; Kristensen J; Olsson K; Bring J; Högman CF
    Vox Sang; 1996; 70(2):69-75. PubMed ID: 8801766
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Platelet activation of platelet concentrates derived from buffy coat and apheresis methods.
    Ali SF
    Transfus Apher Sci; 2011 Feb; 44(1):11-3. PubMed ID: 21277261
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative analysis of platelet concentrates prepared after two hours and overnight storage of buffy coat at room temperature.
    Ojha S; Tirlotkar A; Gupta AM; S H S; Chavan P; Poojary M
    Transfus Apher Sci; 2021 Feb; 60(1):103014. PubMed ID: 33262053
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.